Pharma Trade & Investment: India’s envoy Vikram Doraiswami said opening China to more Indian products—especially pharmaceuticals—plus New Delhi investment would “strengthen” ties, as bilateral trade and India’s deficit with Beijing remain in focus. Ebola Response: In eastern Congo, WHO-backed researchers started a trial of remdesivir, MBP134 antibody therapy, or a combo for Bundibugyo Ebola, as cases top 1,400 with 438 deaths. ESG & Rule of Law: A Chinese legal expert urged stronger legal frameworks and regulatory certainty to expand China-Europe ESG cooperation, arguing it improves the investment environment. Tuition Pressure in Health Education: Public universities across China are raising tuition for incoming students, with medicine and elite programs hit hardest, as local government finances strain. Nuclear Medicine Deal: Sanyou Bio and Baiyunshan Xihe signed a strategic pact to co-develop radiopharmaceuticals and radiodiagnostics, aiming for end-to-end precision oncology innovation. Stress, Gut, and Disease Risk: A study reported chronic psychological stress can disrupt gut microbiome and affect blood-forming stem cells, raising risk for conditions like heart disease and diabetes. Food & Wellness: Hong Kong chefs are bringing lard back to menus, citing research that warns more about trans fats than animal fats.